BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yuan X, Bhat OM, Lohner H, Zhang Y, Li PL. Downregulation of Lysosomal Acid Ceramidase Mediates HMGB1-Induced Migration and Proliferation of Mouse Coronary Arterial Myocytes. Front Cell Dev Biol 2020;8:111. [PMID: 32211403 DOI: 10.3389/fcell.2020.00111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Andersson U, Ottestad W, Tracey KJ. Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19? Mol Med. 2020;26:42. [PMID: 32380958 DOI: 10.1186/s10020-020-00172-4] [Cited by in Crossref: 84] [Cited by in F6Publishing: 87] [Article Influence: 42.0] [Reference Citation Analysis]
2 Ma Z, Yang KY, Huang Y, Lui KO. Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications. J Mol Cell Cardiol 2021;164:69-82. [PMID: 34838588 DOI: 10.1016/j.yjmcc.2021.11.010] [Reference Citation Analysis]
3 Palmblad K, Schierbeck H, Sundberg E, Horne AC, Erlandsson Harris H, Henter JI, Andersson U. Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome. Mol Med 2021;27:48. [PMID: 33975537 DOI: 10.1186/s10020-021-00308-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]